Profilo
Kate Rumrill is currently the President, Chief Executive Officer & Director at Ablative Solutions, Inc. She was previously the President & Chief Executive Officer at NeoSync, Inc.
Posizioni attive di Kate Rumrill
Società | Posizione | Inizio |
---|---|---|
Ablative Solutions, Inc.
Ablative Solutions, Inc. Medical SpecialtiesHealth Technology Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA. | Amministratore Delegato | 11/07/2019 |
Precedenti posizioni note di Kate Rumrill
Società | Posizione | Fine |
---|---|---|
NeoSync, Inc.
NeoSync, Inc. Medical SpecialtiesHealth Technology NeoSync, Inc. is a clinical-stage firm. It develops non-invasive neuromodulation products to treat major depressive disorder and other diseases of the central nervous system. The firm's technology, NeoSync-EEG Synchronized TMS, is personalized to a patient’s individual alpha frequency. The company was founded by Bill Phillips and is headquartered in South Boston, MA. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
NeoSync, Inc.
NeoSync, Inc. Medical SpecialtiesHealth Technology NeoSync, Inc. is a clinical-stage firm. It develops non-invasive neuromodulation products to treat major depressive disorder and other diseases of the central nervous system. The firm's technology, NeoSync-EEG Synchronized TMS, is personalized to a patient’s individual alpha frequency. The company was founded by Bill Phillips and is headquartered in South Boston, MA. | Health Technology |
Ablative Solutions, Inc.
Ablative Solutions, Inc. Medical SpecialtiesHealth Technology Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA. | Health Technology |
- Borsa valori
- Insiders
- Kate Rumrill